19 results
8-K
ZOM
Zomedica Corp
5 Jan 21
Departure of Directors or Certain Officers
4:15pm
industries. Following his earlier tenure at three multi-billion-dollar medical technology companies, Mr. Cohen built shareholder value at a series of smaller
8-K
EX-99.1
ZOM
Zomedica Corp
3 Dec 19
Zomedica Announces Management Changes
4:20pm
capitalizing on the solid foundation built during Jerry’s tenure. The Board, executive team and employees are excited about Zomedica’s future. The Board
8-K
ZOM
Zomedica Corp
17 Jun 20
Departure of Directors or Certain Officers
4:46pm
and President and Chief Executive Officer of Miromatrix Medical, Inc. (“Miromatrix”), a biotechnology device company. During his tenure at Miromatrix
DEF 14A
ZOM
Zomedica Corp
5 Jul 18
Definitive proxy
4:01pm
forth the name, age, position and tenure of each of our directors and executive officers as of February 27, 2018:
Name
Age
Position
Gerald Solensky … specialty pharmacy company in the U.S. During his tenure with Diplomat, the company grew from a single location with less than $5 million in revenue
PRE 14A
r0ame sg0u8
29 Jul 20
Preliminary proxy
5:25pm
10-K
pknr5nebe6xqv9k7 gcm
28 Feb 18
Annual report
12:00am
424B3
4arijt6qxau7yeyb ij
26 Oct 20
Prospectus supplement
9:21am
S-4
oaj3b8udvq 0kg
9 Oct 20
Registration of securities issued in business combination transactions
1:57pm
S-4/A
rr73vuh4
22 Oct 20
Registration of securities issued in business combination transactions (amended)
4:01pm
- Prev
- 1
- Next